Pidolma Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
- Revenue Growth 47.49%
- Profit Growth 139.43%
- Ebitda 137.96%
- Net Worth 91.89%
- Total Assets 76.81%
About Pidolma Healthcare
Pidolma Healthcare Private Limited (PHPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2019 (Five years and ten months 23 days old ). Its registered office is in Kurukshetra, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Company Details
-
Location
Kurukshetra, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299HR2019PTC079060
-
Company No.
079060
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2019
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Pidolma Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Om Parkash
|
Director | 12-Mar-2019 | Current |
|
Gourav
|
Director | 12-Mar-2019 | Current |
Financial Performance of Pidolma Healthcare.
Pidolma Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.49% increase. The company also saw a substantial improvement in profitability, with a 139.43% increase in profit. The company's net worth Soared by an impressive increase of 91.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pidolma Healthcare?
In 2023, Pidolma Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Silhos Pharma LimitedOm Parkash and Gourav are mutual person
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2019 | Others | ₹1.50 M | Open |
How Many Employees Work at Pidolma Healthcare?
Unlock and access historical data on people associated with Pidolma Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pidolma Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pidolma Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.